Key Features
- Synthetic triple agonist peptide targeting GLP‑1, GIP, and glucagon receptor pathways in metabolic research
- Engineered for enhanced peptide stability and receptor specificity
- Used in lab studies investigating endocrine signalling cross-talk and metabolic regulation
- Widely applied in preclinical models for obesity and glucose metabolism research
- Supplied as a high-purity, lyophilised powder for controlled experimental use
Specifications
- Form: Lyophilised peptide powder
- Purity: ≥ 99%
- Verification: Confirmed by HPLC and Mass Spectrometry; batch-specific CoA provided
- Manufacturing: Produced under laboratory-grade controlled conditions
Storage Conditions
- Unreconstituted: −20 °C
- Reconstituted (bacteriostatic water): 2–8 °C (refrigerated)
- Avoid repeated freeze-thaw cycles and direct light exposure
Research Use Only Disclaimer
- For laboratory research purposes only
- Not for human consumption or clinical use
- Must be handled by qualified personnel
Additional Information
-  CAS Number: 2381089‑83‑2
- Molecular Formula: C221H342N46O68



